Maurice James, Pinzani Massimo
University College London Institute for Liver and Digestive Health, Royal Free Hospital, London, UK.
Hepatol Res. 2020 May;50(5):535-541. doi: 10.1111/hepr.13493. Epub 2020 Mar 5.
Cirrhosis is traditionally seen as an irreversible stage of chronic liver disease although its clinical course may last several years. Overall, the clinical management of patients with cirrhosis is based on the observation of clinical events mostly related to complications of portal hypertension. Each event of cirrhosis decompensation has clear prognostic implications although it is not precisely predictable. In practice, the advancement in the knowledge of the mechanisms responsible for disease progression is not yet translated in clinical tools allowing the stratification of the cirrhotic stage according to pathophysiological mechanisms. This article provides a review of the main clinical and histopathological features of liver cirrhosis that are relevant for its clinical stratification together with the advancements provided by the introduction of non-invasive measures of portal hypertension. Other clinical aspects that have a major impact on the quality of life and the possibility of liver transplantation are also discussed.
传统上,肝硬化被视为慢性肝病的不可逆阶段,尽管其临床病程可能持续数年。总体而言,肝硬化患者的临床管理基于对主要与门静脉高压并发症相关的临床事件的观察。肝硬化失代偿的每一个事件都有明确的预后意义,尽管它并不能精确预测。实际上,对疾病进展机制的认识进展尚未转化为能够根据病理生理机制对肝硬化阶段进行分层的临床工具。本文综述了与肝硬化临床分层相关的主要临床和组织病理学特征,以及门静脉高压非侵入性测量方法引入所带来的进展。还讨论了对生活质量和肝移植可能性有重大影响的其他临床方面。